Dario Eklund, Santhera CEO
October 13, 2023 06:00 AM EDTUpdated 10:48 AM
Pharma

San­thera gears up for EU launch of va­morolone in Duchenne af­ter pos­i­tive CHMP opin­ion

Ayisha Sharma

News Reporter

Swiss biotech San­thera has se­cured a pos­i­tive opin­ion for va­morolone from the EU’s CHMP for pa­tients with Duchenne mus­cu­lar dy­s­tro­phy (DMD), spark­ing plans for a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Se­cre­tive Tree­line Bio­sciences dis­clos­es $421M fi­nanc­ing in fil­ing

Benev­o­len­tAI CEO is out af­ter less than a year on the job

FDA ap­proves Ab­b­Vie's 24-hour Parkin­son's in­fu­sion ther­a­py af­ter two CRLs

House’s promi­nent Chi­na crit­ic Jim Mc­Gov­ern leads op­po­si­tion to Biose­cure Act: ‘I would pre­fer to go back to the ...

Mer­ck KGaA eyes more man­u­fac­tur­ing M&A as it faces head­winds in Chi­na

sponsored

Join the Gen­Script Biotech Glob­al Fo­rum: Un­lock­ing In­no­va­tions in Cell and Gene Ther­a­pies

A service from the Financial Times